Publications

Sort by: Date | Author | Title

Rrapaj, A., Landau, A. M. & Winterdahl, M. (2023). Exploration of possible sex bias in acute social stress research: a semi-systematic review. Acta Neuropsychiatrica, 35(4), 1-29. https://doi.org/10.1017/neu.2023.16

Rossi, R., Arjmand, S., Bærentzen, S. L., Gjedde, A. & Landau, A. (2022). Synaptic Vesicle Glycoprotein 2A: Features and Functions. Frontiers in Neuroscience, 16, Article 864514. https://doi.org/10.3389/fnins.2022.864514

Rossi, R., Bærentzen, S. L., Thomsen, M., Real, C. C., Wegener, G., Grassi-Oliveira, R., Gjedde, A. & Landau, A. (2024). A single dose of cocaine raises SV2A density in hippocampus of adolescent rats. Acta Neuropsychiatrica, 36(2), 109-117. https://doi.org/10.1017/neu.2023.14

Ros, R., Garre, P. G., Hirano, M., Tai, Y. F., Ampuero, I., Vidal, L., Rojo, A., Fontan, A., Vazquez, A., Fanjul, S., Hernandez, J., Cantarero, S., Hoenicka, J., Jones, A., Ahsan, R. L., Pavese, N., Piccini, P., Brooks, D. J., Perez-Tur, J. ... De Yébenes, J. G. (2005). Genetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1. Annals of Neurology, 57(5), 634-641. https://doi.org/10.1002/ana.20449

Rønn, L. C. B., Ralets, I., Hartz, B. P., Bech, M., Berezin, A., Berezin, V., Møller, A. & Bock, E. (2000). A simple procedure for quantification of neurite outgrowth based on stereological principles. Journal of Neuroscience Methods, 100, 25-32.

Rømer Thomsen, K., Jønsson, M., Lou, H. O. C., Møller, A., Kringelbach, M. L. & Changeux, J.-P. (2012). Altered self-control and paralimbic activity in pathological gambling. Poster session presented at Psykiatriens 7. Forskningsdag, Aarhus.

Rømer Thomsen, K., Joensson, M., Lou, H. O. C., Møller, A., Gross, J., Kringelbach, M. L. & Changeux, J.-P. (2013). Altered paralimbic interaction in behavioral addiction. Proceedings of the National Academy of Sciences (PNAS), 110(12), 4744-9. https://doi.org/10.1073/pnas.1302374110

Rømer Thomsen, K., Fjorback, L., Møller, A. & Lou, H. C. (2014). Applying incentive sensitization models to behavioral addiction. Neuroscience & Biobehavioral Reviews, 45(2014), 343. https://doi.org/10.1016/j.neubiorev.2014.07.009

Rømer Thomsen, K., Callesen, M. B., Linnet, J. & Møller, A. (2007). Ludomane med depressive symptomer. Poster session presented at Research Day, Aarhus University Hospital, Aarhus, Denmark.

Rømer Thomsen, K., Callesen, M. B., Linnet, J. & Møller, A. (2007). Double Trouble: Pathological Slot Machine Gamblers with Depressive Symptoms.

Rømer Thomsen, K., Callesen, M. B., Linnet, J., Kringelbach, M. L. & Møller, A. (2009). Severity of gambling is Associated with severity of depressive symptoms in pathological gamblers. Behavioural Pharmacology, 20(5-6), 527-36.

Rogers, R. D., Andrews, T. C., Grasby, P. M., Brooks, D. J. & Robbins, T. W. (2000). Contrasting cortical and subcortical activations produced by attentional-set shifting and reversal learning in humans. Journal of Cognitive Neuroscience, 12(1), 142-162. https://doi.org/10.1162/089892900561931

Rodda, J., Okello, A., Edison, P., Dannhauser, T., Brooks, D. J. & Walker, Z. (2010). ¹¹C-PIB PET in subjective cognitive impairment. European Psychiatry, 25(2), 123-125. https://doi.org/10.1016/j.eurpsy.2009.07.011

Rinne, J. O., Brooks, D. J., Rossor, M. N., Fox, N. C., Bullock, R., Klunk, W. E., Mathis, C. A., Blennow, K., Barakos, J., Okello, A. A., de LIano, S. R. M., Liu, E., Koller, M., Gregg, K. M., Schenk, D., Black, R. & Grundman, M. (2010). ¹¹C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study. The Lancet Neurology, 9(4), 363-372. https://doi.org/10.1016/S1474-4422(10)70043-0

Ring, H. A., Bench, C. J., Trimble, M. R., Brooks, D. J., Frackowiak, R. S. J. & Dolan, R. J. (1994). Depression in Parkinson's disease. A positron emission study. British Journal of Psychiatry, 165(SEP.), 333-339.

Richardson, M. P., Hammers, A., Brooks, D. J. & Duncan, J. S. (2001). Benzodiazepine-GABA_A receptor binding is very low in dysembryoplastic neuroepithelial tumor: A PET study. Epilepsia, 42(10), 1327-1334. https://doi.org/10.1046/j.1528-1157.2001.44100.x

Richardson, M. P., Koepp, M. J., Brooks, D. J. & Duncan, J. S. (1998). ¹¹C-flumazenil PET in neocortical epilepsy. Neurology, 51(2), 485-492. https://doi.org/10.1212/WNL.51.2.485

Richardson, M. P., Koepp, M. J., Brooks, D. J., Coull, J. T., Grasby, P., Fish, D. R. & Duncan, J. S. (1998). Cerebral activation in malformations of cortical development. Brain, 121(7), 1295-1304. https://doi.org/10.1093/brain/121.7.1295

Richardson, M. P., Fristen, K. J., Sisodiya, S. M., Koepp, M. J., Ashburner, J., Free, S. L., Brooks, D. J. & Duncan, J. S. (1997). Cortical grey matter and benzodiazepine receptors in malformations of cortical development. A voxel-based comparison of structural and functional imaging data. Brain, 120(11), 1961-1973. https://doi.org/10.1093/brain/120.11.1961

Richardson, M. P., Koepp, M. J., Brooks, D. J., Fish, D. R. & Duncan, J. S. (1996). Benzodiazepine receptors in focal epilepsy with cortical dysgenesis: An ¹¹C-flumazenil PET study. Annals of Neurology, 40(2), 188-198. https://doi.org/10.1002/ana.410400210

Rice, C. M., Mallam, E. A., Whone, A. L., Walsh, P., Brooks, D. J., Kane, N., Butler, S. R., Marks, D. I. & Scolding, N. J. (2010). Safey and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis. Clinical Pharmacology and Therapeutics, 87(6), 679-685. https://doi.org/10.1038/clpt.2010.44

Riaño Barros, D. A., McGinnity, C. J., Rosso, L., Heckemann, R. A., Howes, O. D., Brooks, D. J., Duncan, J. S., Turkheimer, F. E., Koepp, M. J. & Hammers, A. (2014). Test-retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [¹¹C]MePPEP. NeuroImage, 97, 151-62. https://doi.org/10.1016/j.neuroimage.2014.04.020

Reuter, I., Tai, Y. F., Pavese, N., Chaudhuri, K. R., Mason, S., Polkey, C. E., Clough, C., Brooks, D. J., Barker, R. A. & Piccini, P. (2008). Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease. Journal of Neurology, Neurosurgery & Psychiatry, 79(8), 948-951. https://doi.org/10.1136/jnnp.2007.142380

Reuter, I., Hu, M. T. M., Andrews, T. C., Brooks, D. J., Clough, C. & Ray Chaudhuri, K. (2000). Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome. Journal of Neurology Neurosurgery and Psychiatry, 68(2), 238-241. https://doi.org/10.1136/jnnp.68.2.238

Remy, P., Doder, M., Lees, A., Turjanski, N. & Brooks, D. (2005). Depression in Parkinson's disease: Loss of dopamine and noradrenaline innervation in the limbic system. Brain, 128(6), 1314-1322. https://doi.org/10.1093/brain/awh445

Real, C. C., Binda, K. H., Thomsen, M. B., Lillethorup, T. P., Brooks, D. J. & Landau, A. M. (2023). Selecting the Best Animal Model of Parkinson's Disease for Your Research Purpose: Insight from in vivo PET Imaging Studies. Current Neuropharmacology, 21(5), 1241 - 1272. https://doi.org/10.2174/1570159X21666230216101659

Ray Chaudhuri, K., Rojo, J. M., Schapira, A. H. V., Brooks, D. J., Stocchi, F., Odin, P., Antonini, A., Brown, R. J. & Martinez-Martin, P. (2013). A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need. PLoS One, 8(2), e57221. https://doi.org/10.1371/journal.pone.0057221

Ray Chaudhuri, K., Leta, V., Bannister, K., Brooks, D. J. & Svenningsson, P. (2023). The noradrenergic subtype of Parkinson disease: from animal models to clinical practice. Nature Reviews Neurology, 19(6), 333-345. https://doi.org/10.1038/s41582-023-00802-5

Ravina, B., Eidelberg, D., Ahlskog, J. E., Albin, R. L., Brooks, D. J., Carbon, M., Dhawan, V., Feigin, A., Fahn, S., Guttman, M., Gwinn-Hardy, K., McFarland, H., Innis, R., Katz, R. G., Kieburtz, K., Kish, S. J., Lange, N., Langston, J. W., Marek, K. ... Holloway, R. (2005). The role of radiotracer imaging in Parkinson disease. Neurology, 64(2), 208-215. https://doi.org/10.1212/01.WNL.0000149403.14458.7F

Rascol, O., Brooks, D. J., Korczyn, A. D., De Deyn, P. P., Clarke, C. E., Lang, A. E., Abdalla, M., Harmant, J., Jacquy, J., King, D., Martin, W., Destee, A., Durif, F., Aharon-Peretz, J., Reches, A., Bergamasco, B., Bracco, F., Frattolla, L., Nordera, P. ... Wroe, S. V. (2006). Development of dyskinesias in a 5-year trial and ropinirole and L-dopa. Movement Disorders, 21(11), 1844-1850. https://doi.org/10.1002/mds.20988

Rascol, O., Brooks, D. J., Melamed, E., Oertel, W., Poewe, W., Stocchi, F. & Tolosa, E. (2005). Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): A randomised, double-blind, parallel-group trial. Lancet, 365(9463), 947-954. https://doi.org/10.1016/S0140-6736(05)71083-7

Rascol, O., Brooks, D. J., Korczyn, A. D., De Deyn, P. P., Clarke, C. E. & Lang, A. E. (2000). A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. New England Journal of Medicine, 342(20), 1484-1491. https://doi.org/10.1056/NEJM200005183422004

Rascol, O., Brooks, D. J., Brunt, E. R., Korczyn, A. D., Poewe, W. H. & Stocchi, F. (1998). Ropinirole in the treatment of early Parkinson's disease: A 6-month interim report of a 5-year levodopa-controlled study. Movement Disorders, 13(1), 39-45. https://doi.org/10.1002/mds.870130111

Ramlackhansingh, A. F., Bose, S. K., Ahmed, I., Turkheimer, F. E., Pavese, N. & Brooks, D. J. (2011). Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease. Neurology, 76(21), 1811-6. https://doi.org/10.1212/WNL.0b013e31821ccce4

Ramlackhansingh, A. F., Brooks, D. J., Greenwood, R. J., Bose, S. K., Turkheimer, F. E., Kinnunen, K. M., Gentleman, S., Heckemann, R. A., Gunanayagam, K., Gelosa, G. & Sharp, D. J. (2011). Inflammation after trauma: Microglial activation and traumatic brain injury. Annals of Neurology, 70(3), 374-383. https://doi.org/10.1002/ana.22455

Rakshi, J. S., Pavese, N., Uema, T., Ito, K., Morrish, P. K., Bailey, D. L. & Brooks, D. J. (2002). A comparison of the progression of early Parkinson's disease in patients started on ropinirole or L-dopa: An 18F-dopa PET study. Journal of Neural Transmission, 109(12), 1433-1443. https://doi.org/10.1007/s00702-002-0753-0

Rakshi, J. S., Uema, T., Ito, K., Bailey, D. L., Morrish, P. K., Ashburner, J., Dagher, A., Jenkins, I. H., Friston, K. J. & Brooks, D. J. (1999). Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease. A 3D [¹⁸F]dopa-PET study. Brain, 122(9), 1637-1650. https://doi.org/10.1093/brain/122.9.1637

Rajput, A. H., Boecker, H. & Brooks, D. J. (1996). Specificity of ethanol in essential tremor [4]. Annals of Neurology, 40(6), 950-951.

Rahbek, B., Weikop, P., Møller, A., Knudsen, G. M. & Aznar, S. (2006). Serotonin Depletion Results in a Decrease of the Neuronal Activation Caused by Acetylcholine in the Rat Hippocampus. Brain Research, 1073-1074.

Rabey, J. M., Bass, H., Bonuccelli, U., Brooks, D., Klotz, P., Korczyn, A. D., Kraus, P., Martinez-Martin, P., Morrish, P., Van Sauten, W. & Van Hilten, B. (1997). Evaluation of the Short Parkinson's Evaluation Scale: A new friendly scale for the evaluation of Parkinson's disease in clinical drug trials. Clinical Neuropharmacology, 20(4), 322-337. https://doi.org/10.1097/00002826-199708000-00004

Qamhawi, Z., Towey, D., Shah, B., Pagano, G., Seibyl, J., Marek, K., Borghammer, P., Brooks, D. J. & Pavese, N. (2015). Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease. Brain, 138, 2964-2973. https://doi.org/10.1093/brain/awv215

Prevett, M. C., Cunningham, V. J., Brooks, D. J., Fish, D. R. & Duncan, J. S. (1994). Opiate receptors in idiopathic generalised epilepsy measured with [¹¹C]diprenorphine and positron emission tomography. Epilepsy Research, 19(1), 71-77. https://doi.org/10.1016/0920-1211(94)90090-6

Politis, M., Wu, K., Loane, C., Brooks, D. J., Kiferle, L., Turkheimer, F. E., Bain, P., Molloy, S. & Piccini, P. (2014). Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients. Journal of Clinical Investigation. https://doi.org/10.1172/JCI71640

Politis, M., Wu, K., Loane, C., Quinn, N. P., Brooks, D. J., Oertel, W. H., Björklund, A., Lindvall, O. & Piccini, P. (2012). Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts. Science Translational Medicine, 4(128), 128ra41. https://doi.org/10.1126/scitranslmed.3003391

Politis, M., Pavese, N., Tai, Y. F., Kiferle, L., Mason, S. L., Brooks, D. J., Tabrizi, S. J., Barker, R. A. & Piccini, P. (2011). Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study. Human Brain Mapping, 32(2), 258-70. https://doi.org/10.1002/hbm.21008

Politis, M., Sauerbier, A., Loane, C., Pavese, N., Martin, A., Corcoran, B., Brooks, D. J., Ray Chaudhuri, K. & Piccini, P. (2017). Sustained striatal dopamine levels following intestinal levodopa infusions in Parkinson's disease patients. Movement Disorders, 32(2), 235-240. https://doi.org/10.1002/mds.26848

Politis, M., Wilson, H., Wu, K., Brooks, D. J. & Piccini, P. (2017). Chronic exposure to dopamine agonists affects the integrity of striatal D2 receptors in Parkinson's patients. NeuroImage: Clinical, 16, 455-460. https://doi.org/10.1016/j.nicl.2017.08.013

Politis, M., Loane, C., Wu, K., Brooks, D. J. & Piccini, P. (2011). Serotonergic mediated body mass index changes in Parkinson's disease. Neurobiology of Disease, 43(3), 609-615. https://doi.org/10.1016/j.nbd.2011.05.009

Politis, M., Oertel, W. H., Wu, K., Quinn, N. P., Pogarell, O., Brooks, D. J., Bjorklund, A., Lindvall, O. & Piccini, P. (2011). Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio. Movement Disorders, 26(11), 1997-2003. https://doi.org/10.1002/mds.23743

Politis, M., Wu, K., Loane, C., Turkheimer, F. E., Molloy, S., Brooks, D. J. & Piccini, P. (2010). Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures. Neurology, 75(21), 1920-1927. https://doi.org/10.1212/WNL.0b013e3181feb2ab

Politis, M., Wu, K., Loane, C., Kiferle, L., Molloy, S., Brooks, D. J. & Piccini, P. (2010). Staging of serotonergic dysfunction in Parkinson's Disease: An in vivo ¹¹C-DASB PET study. Neurobiology of Disease, 40(1), 216-221. https://doi.org/10.1016/j.nbd.2010.05.028

Politis, M., Wu, K., Loane, C., Quinn, N. P., Brooks, D. J., Rehncrona, S., Bjorklund, A., Lindvall, O. & Piccini, P. (2010). Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Science Translational Medicine, 2(38), Article 38ra46. https://doi.org/10.1126/scitranslmed.3000976

Politis, M., Piccini, P., Pavese, N., Koh, S. B. & Brooks, D. J. (2008). Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: An in vivo 11C-raclopride PET study. Experimental Neurology, 214(1), 112-116. https://doi.org/10.1016/j.expneurol.2008.07.021

Politis, M., Pavese, N., Tai, Y. F., Tabrizi, S. J., Barker, R. A. & Piccini, P. (2008). Hypothalamic involvement in Huntington's disease: An in vivo PET study. Brain, 131(11), 2860-2869. https://doi.org/10.1093/brain/awn244

Playford, E. D., Passingham, R. E., Marsden, C. D. & Brooks, D. J. (1998). Increased activation of frontal areas during arm movement in idiopathic torsion dystonia. Movement Disorders, 13(2), 309-318. https://doi.org/10.1002/mds.870130218

Playford, E. D., Fletcher, N. A., Sawle, G. V., Marsden, C. D. & Brooks, D. J. (1993). Striatal (¹⁸F)dopa uptake in familial idiopathic dystonia. Brain, 116(5), 1191-1199. https://doi.org/10.1093/brain/116.5.1191

Playford, E. D., Jenkins, I. H., Passingham, R. E., Frackowiak, R. S. & Brooks, D. J. (1993). Impaired activation of frontal areas during movement in Parkinson's disease: a PET study. Advances in neurology, 60, 506-510.

Playford, E. D., Fletcher, N. A., Sawle, G. V., Marsden, C. D. & Brooks, D. J. (1993). Striatal [18F]dopa uptake in familial idiopathic dystonia. Brain, 116.

Playford, E. D. & Brooks, D. J. (1992). In vivo and in vitro studies of the dopaminergic system in movement disorders. Cerebrovascular and brain metabolism reviews, 4(2), 144-171.

Pitkänen, A., Mathiesen, C., Rønn, L. C. B., Møller, A. & Nissinen, J. (2007). Effect of novel AMPA antagonist, NS 1209, on status epilepticus, an experimental study in rat. Epilepsy Research, (3780), 1-10.

Pineda-Pardo, J. D. S. A., Sánchez-Ferro, Á., Monje, M. H. G., Pavese, N. & Obeso, J. A. (2022). Onset pattern of nigrostriatal denervation in early Parkinson's disease. Brain, 145(3), 1018-1028. https://doi.org/10.1093/brain/awab378

Pilegaard, A. M., Berendt, M., Holst, P., Møller, A. & McEvoy, F. J. (2017). Effect of Skull Type on the Relative Size of Cerebral Cortex and Lateral Ventricles in Dogs. Frontiers in Veterinary Science, 4(MAR), 30. Article 30. https://doi.org/10.3389/fvets.2017.00030

Piccini, P. & Brooks, D. J. (2006). New developments of brain imaging for Parkinson's Disease and related disorders. Movement Disorders, 21(12), 2035-2041. https://doi.org/10.1002/mds.20845

Piccini, P., Pavese, N., Hagell, P., Reimer, J., Björklund, A., Oertel, W. H., Quinn, N. P., Brooks, D. J. & Lindvall, O. (2005). Factors affecting the clinical outcome after neural transplantation in Parkinson's disease. Brain, 128(12), 2977-2986. https://doi.org/10.1093/brain/awh649

Piccini, P., Pavese, N. & Brooks, D. J. (2003). Endogenous dopamine release after pharmacological challenges in Parkinson's disease. Annals of Neurology, 53(5), 647-653. https://doi.org/10.1002/ana.10526

Piccini, P., De Yebenez, J., Lees, A. J., Ceravolo, R., Turjanski, N., Pramstaller, P. & Brooks, D. J. (2001). Familial progressive supranuclear palsy: Detection of subclinical cases using ¹⁸F-dopa and ¹⁸fluorodeoxyglucose positron emission tomography. Archives of Neurology, 58(11), 1846-1851. https://doi.org/10.1001/archneur.58.11.1846

Piccini, P., Lindvall, O., Björklund, A., Brundin, P., Hagell, P., Ceravolo, R., Oertel, W., Quinn, N., Samuel, M., Rehncrona, S., Widner, H. & Brooks, D. J. (2000). Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Annals of Neurology, 48(5), 689-695. https://doi.org/10.1002/1531-8249(200011)48:5<689::AID-ANA1>3.0.CO;2-N

Piccini, P., Brooks, D. J., Björklund, A., Gunn, R. N., Grasby, P. M., Rimoldi, O., Brundin, P., Hagell, P., Rehncrona, S., Widner, H. & Lindvall, O. (1999). Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nature Neuroscience, 2(12), 1137-1140. https://doi.org/10.1038/16060

Piccini, P., Burn, D. J., Ceravolo, R., Maraganore, D. & Brooks, D. J. (1999). The role of inheritance in sporadic Parkinson's disease: Evidence from a longitudinal study of dopaminergic function in twins. Annals of Neurology, 45(5), 577-582. https://doi.org/10.1002/1531-8249(199905)45:5<577::AID-ANA5>3.0.CO;2-O

Piccini, P. & Brooks, D. J. (1999). Etiology of Parkinson's disease: contributions from 18F-DOPA positron emission tomography. Advances in neurology, 80, 227-231.

Piccini, P., Brooks, D. J., Korpela, K., Pavese, N., Karlsson, M. & Gordin, A. (2000). The catechol-O-methyltransferase (COMT) inhibitor entacapone enhances the pharmacokinetic and clinical response to Sinemet CR in Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry, 68(5), 589-594. https://doi.org/10.1136/jnnp.68.5.589

Piccini, P., Weeks, R. A. & Brooks, D. J. (1997). Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias. Annals of Neurology, 42(5), 720-726. https://doi.org/10.1002/ana.410420508

Piccini, P., Morrish, P. K., Turjanski, N., Sawle, G. V., Burn, D. J., Weeks, R. A., Mark, M. H., Maraganore, D. M., Lees, A. J. & Brooks, D. J. (1997). Dopaminergic function in familial Parkinson's disease: A clinical and ¹⁸F-dopa positron emission tomography study. Annals of Neurology, 41(2), 222-229. https://doi.org/10.1002/ana.410410213

Piccini, P., Turjanski, N. & Brooks, D. J. (1995). PET studies of the striatal dopaminergic system in Parkinson's disease (PD). Journal of Neural Transmission, Supplement, (45), 123-131.

Piccini, P., Pavese, N., Hagell, P., Reimer, J., Bjorklund, A., Oertel, W. H., Quinn, N. P., Brooks, D. J. & Lindvall, O. (2006). Reply: Rate of progression determines the clinical outcome after neural transplantation in Parkinson's disease [2]. Brain, 129(7). https://doi.org/10.1093/brain/awl113

Piccini, P., Pavese, N., Bonuccelli, U., Distante, A., Palombo, C. & Pittella, G. (1995). Transcranial Doppler Ultrasound in Migraine and Tension-Type Headache After Apomorphine Administration: Double-Blind Crossover Versus Placebo Study. Cephalalgia, 15(5), 399-403. https://doi.org/10.1046/j.1468-29821995.1505399.x

Piccini, P., Pavese, N., Canapicchi, R., Paoli, C., Del Dotto, P., Puglioli, M., Rossi, G. & Bonuccelli, U. (1995). White Matter Hyperintensities in Parkinson's Disease: Clinical Correlations. Archives of Neurology, 52(2), 191-194. https://doi.org/10.1001/archneur.1995.00540260097023

Piccini, P., Pavese, N., Palombo, C., Pittella, G., Distante, A. & Bonuccelli, U. (1995). Transcranial Doppler ultrasound in migraine and tension‐type headache after apomorphine administration: double‐blind crossover versus placebo study. Cephalalgia, 15(5), 399-403. https://doi.org/10.1046/j.1468-2982.1995.1505399.x

Piccini, P., Del Dotto, P., Bertolucci, A., Bartolini, S., D'Antonio, P., Pavese, N. & Bonuccelli, U. (1992). IL TEST ALL'APOMORFINA SOTTOCUTANEO E SUBLINGUALE NEL MORBO DI PARKINSON. Rivista di Neurobiologia, 38(6), 527-533.

Phan, J.-A., Jakobsen, S., Landau, A. M., Doudet, D. & Gjedde, A. (2012). Amphetamine-induced inhibition of [C-11]yohimbine binding in rat brain. Poster session presented at The Ninth International Symposium on Functional Neuroreceptor Mapping of the Living Brain (NRM2012), Baltimore, United States.

Phan, J.-A., Landau, A. M., Jakobsen, S., Doudet, D. & Gjedde, A. (2013). Differential Amphetamine and Ligand Concentration Inhibition of 11C-Yohimbine binding in Brain: Effect of Plasma Protein Binding Displacement..

Phan, J.-A., Landau, A. M., Gjedde, A. & Romero-Ramos, M. (2013). Noradrenergic Protection of Dopaminergic Transmission in Parkinson's Disease. Poster session presented at The Brain Prize Meeting 2013, MIddelfart, Denmark.

Phan, J.-A., Landau, A. M., Wong, D. F., Jakobsen, S., Nahimi, A., Doudet, D. J. & Gjedde, A. (2015). Quantification of [(11)C]yohimbine binding to α2 adrenoceptors in rat brain in vivo. Journal of Cerebral Blood Flow and Metabolism, 35(3), 501-511. https://doi.org/10.1038/jcbfm.2014.225

Phan, J.-A., Stokholm, K., Zareba-Paslawska, J., Jakobsen, S., Vang, K., Gjedde, A., Landau, A. M. & Romero-Ramos, M. (2017). Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease. Scientific Reports, 7(1), Article 6363. https://doi.org/10.1038/s41598-017-06724-9

Phan, J.-A., Landau, A. M., Jakobsen, S. & Gjedde, A. (2017). Radioligand binding analysis of α 2 adrenoceptors with [11C]yohimbine in brain in vivo: Extended Inhibition Plot correction for plasma protein binding. Scientific Reports, 7(7), Article 15979. https://doi.org/10.1038/s41598-017-16020-1

Peterson, E., Gjedde, A., Rodell, A., Cumming, P., Møller, A. & Linnet, J. (2006). High sensation seeking men have increased dopamine binding in the right putamen determined from raclopride binding potentials. Poster session presented at 7th Annual Conference on Gambling and Addiction, Las Vegas, United States.

Peterson, E., Gjedde, A., Rodell, A., Cumming, P., Møller, A. & Linnet, J. (2006). Dopamine receptor availability linked to dopamine occupancy during gambling. Poster session presented at 6th Neuroreceptor Mapping Symposium, Copenhagen, Denmark.

Peterson, E., Gjedde, A., Møller, A., Linnet, J., Doudet, D. & Rodell, A. (2008). Comparison of four methods of measurement on [11C]Raclopride binding potential using regional specificity in the striatum. Poster session presented at Dopamine 50 Years, Sweden.

Peterson, E., Gjedde, A., Doudet, D., Møller, A. & Linnet, J. (2008). The Thrill of Risk: Dopaminergic Neurotransmission in Pathological Gambling. Poster session presented at Aarhus University Hospital Research Day, Denmark.

Peterson, E., Møller, A., Doudet, D., Bailey, C., Hansen, K. V., Rodell, A., Linnet, J. & Gjedde, A. (2010). Pathological gambling: relation of skin conductance response to dopaminergic neurotransmission and sensation-seeking . European Neuropsychopharmacology, 20(11), 766-75.

Perrild, H., Møller, A., Pedersen, H. & Siersbæk-Nielsen, K. (1988). Undetectable thyrotropin levels using immunoradiometric assay in L-dopa-treated patients. Nevrologicheskii Zhurnal, 235, 255.

Perrild, H., Møller, A., Baastrup, P. C., Kastberg, S. & Hegedüs, L. (1987). Antibodies directed against determinants in the pituitary gland in lithium treated patients. IRL Press limited, Oxford, 185-7.

Perrild, H., Hegedüs, L., Båstrup, P. C., Kastberg, S., Feldt-Rasmussen, U., Beck, K., Madsen, M. H., Kayser, L., Møller, A., Hansen, G. N. & Hansen, B. L. (1991). Autoimmunity in manicdepressive patients given long-term lithium treatment. Lithium, 2, 155-61.

Perrild, H., Hegedüs, L., Båstrup, P. C., Kastberg, S., Feldt-Rasmussen, U., Bech, K., Madsen, M. H., Kayser, L., Møller, A. & Hansen, B. L. (1990). Thyroid autoimmunity in untreated and lithium treated patients with manic depressive disease. In The Thyroid gland, environment and autoimmunity: proceedings of the International Symposium on Thyroid Gland, Environment and Autoimmunity (pp. 331-2). Elsevier.

Perraudeau, M., Scott, J., Walport, M., Oakley, C., Bloom, S. & Brooks, D. (1994). Late presentation of Kartagener's syndrome. British Medical Journal, 308(6927), 519-521.

Pérez, M., Hoppe, J., Landau, A. M. & Winterdahl, M. (2023). Development and validation of the Male Post-coital Affect Scale for heterosexual men. Acta Neuropsychiatrica, 35(4), 1-6. Article 2300012. https://doi.org/10.1017/neu.2023.12

Peraza, L. R., Nesbitt, D. J., Lawson, R. A., Duncan, G. W., Yarnall, A. J., Khoo, T. K., Kaiser, M., Firbank, M. J., O'Brien, J. T., Barker, R. A., Brooks, D. J., Burn, D. J. & Taylor, J.-P. (2017). Intra-and Inter-Network Functional Alterations in Parkinson's Disease with Mild Cognitive Impairment. Human Brain Mapping, 38(3), 1702-1715. https://doi.org/10.1002/hbm.23499

Perani, D., Iaccarino, L., Lammertsma, A. A., Windhorst, A. D., Edison, P., Boellaard, R., Hansson, O., Nordberg, A., Jacobs, A. H. & Partners IMBI Project (2019). A new perspective for advanced positron emission tomography-based molecular imaging in neurodegenerative proteinopathies. Alzheimer's & Dementia, 15(8), 1081-1103. https://doi.org/10.1016/j.jalz.2019.02.004

IMBI Brain Imaging Working Group (2019). Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 11, 327-332. https://doi.org/10.1016/j.dadm.2019.02.004

Pedersen, K., Simonsen, M., Østergaard, S. D., Munk, O. L., Rosa-Neto, P., Olsen, A. K., Jensen, S. B., Møller, A. & Cumming, P. (2007). Mapping the amphetamine-evoked changes in [¹¹C]raclopride binding in living rat using small animal PET: modulation by MAO-inhibition. NeuroImage, 35(1), 38-46. https://doi.org/10.1016/j.neuroimage.2006.11.038

Pavese, N., Simpson, B. S., Metta, V., Ramlackhansingh, A., Chaudhuri, K. R. & Brooks, D. J. (2012). [¹⁸F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [¹⁸F]FDOPA and [¹¹C]DASB PET study in Parkinson's disease. NeuroImage, 59(2), 1080-4. https://doi.org/10.1016/j.neuroimage.2011.09.034

Pavese, N., Rivero-Bosch, M., Lewis, S. J., Whone, A. L. & Brooks, D. J. (2011). Progression of monoaminergic dysfunction in Parkinson's disease: a longitudinal 18F-dopa PET study. NeuroImage, 56(3), 1463-8. https://doi.org/10.1016/j.neuroimage.2011.03.012

Pavese, N. & Tai, Y. F. (2016). Genetic and degenerative disorders primarily causing other movement disorders. In Neuroimaging Part I, 2016 (Vol. 135, pp. 507-23) https://doi.org/10.1016/B978-0-444-53485-9.00025-8

Pavese, N., Rodemark, S., Tai, Y. F., Yousif, N., Nandi, D. & Bain, P. G. (2016). Traditional trial-and-error versus neuroanatomical-3D-image software-assisted deep brain stimulation programming in patients with Parkinson's disease. Movement Disorders, 31, S30-S31.

Pavese, N. (2013). Dystonia: hopes for a better diagnosis and a treatment with long-lasting effect. Brain, 136(Pt 3), 694-5. https://doi.org/10.1093/brain/awt028

Pavese, N. (2012). PET studies in Parkinson's disease motor and cognitive dysfunction. Parkinsonism & Related Disorders, 18 Suppl 1, S96-9. https://doi.org/10.1016/S1353-8020(11)70031-1

Pavese, N., Moore, R. Y., Scherfler, C., Khan, N. L., Hotton, G., Quinn, N. P., Bhatia, K. P., Wood, N. W., Brooks, D. J., Lees, A. J. & Piccini, P. (2010). In vivo assessment of brain monoamine systems in parkin gene carriers: A PET study. Experimental Neurology, 222(1), 120-124. https://doi.org/10.1016/j.expneurol.2009.12.021

Pavese, N., Politis, M., Tai, Y. F., Barker, R. A., Tabrizi, S. J., Mason, S. L., Brooks, D. J. & Piccini, P. (2010). Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriers. Neurobiology of Disease, 37(2), 356-361. https://doi.org/10.1016/j.nbd.2009.10.015

Pavese, N., Metta, V., Bose, S. K., Chaudhuri, K. R. & Brooks, D. J. (2010). Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction. Brain, 133(11), 3434-3443. https://doi.org/10.1093/brain/awq268

Pavese, N., Khan, N. L., Scherfler, C., Cohen, L., Brooks, D. J., Wood, N. W., Bhatia, K. P., Quinn, N. P., Lees, A. J. & Piccini, P. (2009). Nigrostriatal dysfunction in homozygous and heterozygous Parkin gene carriers: An¹⁸F-dopa PET progression study. Movement Disorders, 24(15), 2260-2266. https://doi.org/10.1002/mds.22817

Pavese, N. & Brooks, D. J. (2009). Imaging neurodegeneration in Parkinson's disease. Biochimica et Biophysica Acta - Molecular Basis of Disease, 1792(7), 722-729. https://doi.org/10.1016/j.bbadis.2008.10.003

Pavese, N., Evans, A. H., Tai, Y. F., Hotton, G., Brooks, D. J., Lees, A. J. & Piccini, P. (2006). Clinical correlates of levodopa-induced dopamine release in Parkinson disease: A PET study. Neurology, 67(9), 1612-1617. https://doi.org/10.1212/01.wnl.0000242888.30755.5d

Pavese, N., Gerhard, A., Tai, Y. F., Ho, A. K., Turkheimer, F., Barker, R. A., Brooks, D. J. & Piccini, P. (2006). Microglial activation correlates with severity in Huntington disease: A clinical and PET study. Neurology, 66(11), 1638-1643. https://doi.org/10.1212/01.wnl.0000222734.56412.17

Pavese, N., Rimoldi, O., Gerhard, A., Brooks, D. J. & Piccini, P. (2004). Cardiovascular effects of methamphetamine in Parkinson's disease patients. Movement Disorders, 19(3), 298-303. https://doi.org/10.1002/mds.10651

Pavese, N., Andrews, T. C., Brooks, D. J., Ho, A. K., Rosser, A. E., Barker, R. A., Robbins, T. W., Sahakian, B. J., Dunnett, S. B. & Piccini, P. (2003). Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: A pet study. Brain, 126(5), 1127-1135. https://doi.org/10.1093/brain/awg119

Pavese, N. & Tai, Y. F. (2018). Nigrosome Imaging and Neuromelanin Sensitive MRI in Diagnostic Evaluation of Parkinsonism. Movement Disorders Clinical Practice, 5(2), 131-140. https://doi.org/10.1002/mdc3.12590

Pavese, N. (2014). Imaging the Aetiology of Sleep Disorders in Dementia and Parkinson’s Disease. Current Neurology and Neuroscience Reports, 14(501). https://doi.org/10.1007/s11910-014-0501-5

Pavese, N. (2012). Do we still need to develop new imaging biomarkers of dopamine denervation for Parkinson's disease? Experimental Neurology, 233(1), 118-120. https://doi.org/10.1016/j.expneurol.2011.10.008

Pavese, N. & Brooks, D. J. (2011). Functional neuroanatomy and physiology in movement disorders. In Rehabilitation in Movement Disorders (pp. 1-13). Cambridge University Press. https://doi.org/10.1017/CBO9781139012942.002

Pavese, N., Kiferle, L. & Piccini, P. (2009). Neuroprotection and imaging studies in Parkinson's disease. Parkinsonism and Related Disorders, 15(SUPPL. 4). https://doi.org/10.1016/S1353-8020(09)70832-6

Pavese, N., Giannaccini, G., Betti, L., Ferrari, S., Bonanni, E., Bonuccelli, U., Murri, L. & Lucacchini, A. (2000). Peripheral-type benzodiazepine receptors in human blood cells of patients affected by migraine without aura. Neurochemistry International, 37(4), 363-368. https://doi.org/10.1016/S0197-0186(00)00039-5

Pavese, N., Napolitano, A., De Laco, G., Canapicchi, R., Collavoli, P. L., Lucetti, C., Gambaccini, G. & Bonuccelli, U. (1999). Clinical outcome and magnetic resonance imaging of carbon monoxide intoxication. A long-term follow-up study. Italian Journal of Neurological Sciences, 20(3), 171-178. https://doi.org/10.1007/s100720050028

Pavese, N., Baracchini, G. & Bonuccelli, U. (1994). Valproate‐Withdrawal Induced Migraine. Headache: The Journal of Head and Face Pain, 34(7), 445. https://doi.org/10.1111/j.1526-4610.1994.hed3407445_1.x

Pavese, N., Nuti, A., Bibbiani, F., Lucetti, C., Bonuccelli, U., Canapicchi, R. & Collavoli, P. (1994). White matter MRI hyperintensities in a hundred and twenty-nine consecutive migraine patients. Cephalalgia, 14(5), 342-345. https://doi.org/10.1046/j.1468-2982.1994.1405342.x

Pavese, N. (2019). Is neuromelanin the imaging biomarker for the early diagnosis of Parkinson's disease that we were looking for? Parkinsonism and Related Disorders, 58, 1-2. https://doi.org/10.1016/j.parkreldis.2018.12.013

Pavese, N., Tai, Y. F., Yousif, N., Nandi, D. & Bain, P. G. (2020). Traditional Trial and Error versus Neuroanatomic 3-Dimensional Image Software-Assisted Deep Brain Stimulation Programming in Patients with Parkinson Disease. World Neurosurgery, 134, e98-e102. https://doi.org/10.1016/j.wneu.2019.09.106

Pavese, N. (2021). Atypical Parkinsonian Syndromes and Subtypes of Parkinson's Disease. Will a Single Neuroimaging Modality Ever Be Enough? Movement Disorders Clinical Practice, 8(2), 172-174. https://doi.org/10.1002/mdc3.13137

Patel, N. K., Pavese, N., Javed, S., Hotton, G. R., Brooks, D. J. & Gill, S. S. (2013). Benefits of putaminal GDNF infusion in Parkinson disease are maintained after GDNF cessation. Neurology, 81(13), 1176-8. https://doi.org/10.1212/WNL.0b013e3182a55ea5

Pasquini, J., Ceravolo, R., Qamhawi, Z., Lee, J.-Y., Deuschl, G., Brooks, D. J., Bonuccelli, U. & Pavese, N. (2018). Progression of tremor in early stages of Parkinson's disease: a clinical and neuroimaging study. Brain, 141(3), 811-821. https://doi.org/10.1093/brain/awx376

Pasquini, J., Ceravolo, R., Brooks, D. J., Bonuccelli, U. & Pavese, N. (2020). Progressive loss of raphe nuclei serotonin transporter in early Parkinson's disease: A longitudinal ¹²³I-FP-CIT SPECT study. Parkinsonism & Related Disorders, 77, 170-175. https://doi.org/10.1016/j.parkreldis.2019.03.025

Pasquini, J., Durcan, R., Wiblin, L., Gersel Stokholm, M., Rochester, L., Brooks, D. J., Burn, D. & Pavese, N. (2019). Clinical implications of early caudate dysfunction in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 90(10), 1098-1104. https://doi.org/10.1136/jnnp-2018-320157

Pasquini, J. & Pavese, N. (2021). Striatal dopaminergic denervation and hypomimia in Parkinson's disease. European Journal of Neurology, 28(1), e2-e3. https://doi.org/10.1111/ene.14483

Pasquini, J., Brooks, D. J. & Pavese, N. (2021). The Cholinergic Brain in Parkinson's Disease. Movement Disorders Clinical Practice, 8(7), 1012-1026. https://doi.org/10.1002/mdc3.13319

Pasquini, J., Deuschl, G., Pecori, A., Salvadori, S., Ceravolo, R. & Pavese, N. (2023). The Clinical Profile of Tremor in Parkinson's Disease. Movement Disorders Clinical Practice, 10(10), 1496-1506. https://doi.org/10.1002/mdc3.13845

Pasquini, J., Firbank, M. J., Ceravolo, R., Silani, V. & Pavese, N. (2022). Diffusion Magnetic Resonance Imaging Microstructural Abnormalities in Multiple System Atrophy: A Comprehensive Review. Movement Disorders, 37(10), 1963-1984. https://doi.org/10.1002/mds.29195

Pasquini, J., Firbank, M. J., Best, L., Foster, V., Galley, D., Silani, V., Ceravolo, R., Petrides, G., Brooks, D. J., Anderson, K. N. & Pavese, N. (2024). Hypothalamic involvement in multiple system atrophy: A structural MRI study. Journal of the Neurological Sciences, 460, Article 122985. https://doi.org/10.1016/j.jns.2024.122985

Pasquini, J., Sigurdsson, H. P., Firbank, M., Best, L., Foster, V., Galley, D., Maxwell, R., Silani, V., Ceravolo, R., Petrides, G., Brooks, D. J. & Pavese, N. (2025). Locus coeruleus neuromelanin, cognitive dysfunction, and brain metabolism in multiple system atrophy. Journal of Neurology, 272(3), 195. Article 195. https://doi.org/10.1007/s00415-025-12932-5

Pasquini, J., Firbank, M. J., Best, L., Foster, V., Stewart, C., Silani, V., Durcan, R., Roberts, G., Petrides, G., Ceravolo, R., Brooks, D. J., Anderson, K. N. & Pavese, N. (2025). Substantia nigra and locus coeruleus microstructural abnormalities in isolated rapid eye movement sleep behaviour disorder and Parkinson's disease. Brain Communications, 7(1), fcaf023. Article fcaf023. https://doi.org/10.1093/braincomms/fcaf023

Pasquini, J., Brooks, D. J. & Pavese, N. (2025). The involvement of the cholinergic system in Parkinson disease. In C. Cuello (Ed.), Cholinergic Involvement in Neurodegenerative Diseases (pp. 215-229). Elsevier. https://doi.org/10.1016/B978-0-443-19088-9.00001-9

Pasquini, J., Pavese, N., Ceravolo, R., Helmich, R. C. & Deuschl, G. (2025). Contralateral Spread of Asymmetrical Tremor in Parkinson's Disease. Movement Disorders Clinical Practice. Advance online publication. https://doi.org/10.1002/mdc3.70353

Pasqualetti, G., Brooks, D. J. & Edison, P. (2015). The Role of Neuroinflammation in Dementias. Current Neurology and Neuroscience Reports, 15(4), Article 17. https://doi.org/10.1007/s11910-015-0531-7

Parbo, P., Ismail, R., Hansen, K. V., Amidi, A., Mårup, F. H., Gottrup, H., Brændgaard, H., Eriksson, B. O. M., Eskildsen, S. F., Lund, T. E., Tietze, A., Edison, P., Pavese, N., Stokholm, M. G., Borghammer, P., Hinz, R., Aanerud, J. & Brooks, D. J. (2017). Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer's disease. Brain, 140(7), 2002-2011. https://doi.org/10.1093/brain/awx120

Parbo, P., Ismail, R., Sommerauer, M., Stokholm, M. G., Hansen, A. K., Hansen, K. V., Amidi, A., Schaldemose, J. L., Gottrup, H., Brændgaard, H., Eskildsen, S. F., Borghammer, P., Hinz, R., Aanerud, J. & Brooks, D. J. (2018). Does inflammation precede tau aggregation in early Alzheimer's disease? A PET study. Neurobiology of Disease, 117, 211-216. https://doi.org/10.1016/j.nbd.2018.06.004

Parbo, P., Madsen, L. S., Ismail, R., Zetterberg, H., Blennow, K., Eskildsen, S. F., Vorup-Jensen, T. & Brooks, D. J. (2020). Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer's disease. Alzheimer's Research & Therapy, 12(1), Article 3. https://doi.org/10.1186/s13195-019-0574-0

Paranathala, M. P., Mills, R., Rai, P., Pavese, N., Hussain, M. A., Duddy, M., Nicholson, C. & Jenkins, A. (2025). Patient selection and outcome of deep brain stimulation for multiple sclerosis-associated tremor. British Journal of Neurosurgery, 39(4), 465-470. https://doi.org/10.1080/02688697.2023.2277284

Paoli, D., Mills, R., Brechany, U., Pavese, N. & Nicholson, C. (2023). DBS in tremor with dystonia: VIM, GPi or both? A review of the literature and considerations from a single-center experience. Journal of Neurology, 270(4), 2217-2229. https://doi.org/10.1007/s00415-023-11569-6

Palmqvist, S., Zetterberg, H., Blennow, K., Vestberg, S., Andreasson, U., Brooks, D. J., Owenius, R., Hägerström, D., Wollmer, P., Minthon, L. & Hansson, O. (2014). Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography. JAMA Neurology, 71(10), 1282-9. https://doi.org/10.1001/jamaneurol.2014.1358

Palermo, G., Giannoni, S., Frosini, D., Morganti, R., Volterrani, D., Bonuccelli, U., Pavese, N. & Ceravolo, R. (2020). Dopamine Transporter, Age, and Motor Complications in Parkinson's Disease: A Clinical and Single-Photon Emission Computed Tomography Study. Movement Disorders, 35(6), 1028-1036. https://doi.org/10.1002/mds.28008

Palermo, G., Giannoni, S., Tommasini, L., Bellini, G., Frosini, D., Aghakhanyan, G., Morganti, R., Volterrani, D., Pavese, N. & Ceravolo, R. (2025). Exploring the Distinct Effect of Age at Onset and Caudate Denervation on Cognitive Deficits in Early Parkinson’s Disease. Aging and Disease, 16(3), 1754-1768. https://doi.org/10.14336/AD.2024.0553

Palermo, G., Aghakhanyan, G., Bellini, G., Giannoni, S., Vadi, G., Francischello, R., Nonne, G., Tedeschi, M. G., Morganti, R., Frosini, D., Pavese, N., Volterrani, D. & Ceravolo, R. (2025). Discriminating between proposed Brain-First and Body-First Parkinson’s disease using conventional and radiomics-enhanced dopamine transporter SPECT image analysis. npj Parkinson's Disease , 11(1), Article 328. https://doi.org/10.1038/s41531-025-01164-z

Pakkenberg, B., Evans, S. M., Møller, A., Brændgaard, H. & Gundersen, H. J. (1989). Total number of neurons in human neocortex related to age and sex estimated by way of optical disectors. Acta Stereologica, 8, 251-256.

Pakkenberg, B., Møller, A., Gundersen, H. J., Dam, A. M. & Pakkenberg, H. (1991). The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. Journal of Neurology, Neurosurgery & Psychiatry, 54, 30-3.

Pakkenberg, B., Evans, S. M., Møller, A., Brændgaard, H. & Gundersen, H. J. (1991). Sex and age differences in total neuron number in human neocortex estimated using optical disectors. Neuropathology Supplement, 4, 493-495.

Pakkenberg, B., Andersen, B. B., Jensen, G. B., Korbo, L., Mouton, P. R., Møller, A., Regeur, L. & Øster, S. (1992). The impact of the new stereology on the neurosciences - neurostereology. Acta Stereology Suppl, 11, 157-164.

Pagano, G., Molloy, S., Bain, P. G., Rabiner, E. A., Chaudhuri, K. R., Pavese, N. & Brooks, D. (2016). Sleep problems and hypothalamic dopamine D3 receptor availability in Parkinson disease. Neurology, 87(23), 2451-2456. https://doi.org/10.1212/WNL.0000000000003396

Pagano, G., Ferrara, N., Brooks, D. J. & Pavese, N. (2016). Age at onset and Parkinson disease phenotype. Neurology, 86(15), 1400-1407. https://doi.org/10.1212/WNL.0000000000002461

Pagano, G., Molloy, S., Bain, P., Rabiner, E., Chaudhuri, K., Brooks, D. & Pavese, N. (2020). Impulse control disorder and ventral striatum dopamine D3 receptor availability in Parkinson's disease. Movement Disorders, 35, S261-S261. https://doi.org/10.1002/mds.28268

Pagano, G., Molloy, S., Bain, P., Rabiner, E., Chaudhuri, K., Brooks, D. & Pavese, N. (2020). Levodopa-induced dyskinesias and substantia nigra dopamine D3 receptor availability in Parkinson's disease. Movement Disorders, 35, S261-S261. https://doi.org/10.1002/mds.28268

Pagano, G., Molloy, S., Bain, P. G., Rabiner, E. A., Ray Chaudhuri, K., Brooks, D. J. & Pavese, N. (2021). Impulse control disorders are associated with lower ventral striatum dopamine D3 receptor availability in Parkinson's disease: A [¹¹C]-PHNO PET study. Parkinsonism and Related Disorders, 90, 52-56. https://doi.org/10.1016/j.parkreldis.2021.06.025

the PASADENA Investigators and Prasinezumab Study Group (2022). Trial of Prasinezumab in Early-Stage Parkinson's Disease. New England Journal of Medicine, 387(5), 421-432. https://doi.org/10.1056/NEJMoa2202867

Ostrowitzki, S., Deptula, D., Thurfjell, L., Barkhof, F., Bohrmann, B., Brooks, D. J., Klunk, W. E., Ashford, E., Yoo, K., Xu, Z.-X., Loetscher, H. & Santarelli, L. (2012). Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab. Archives of Neurology, 69(2), 198-207. https://doi.org/10.1001/archneurol.2011.1538

Østergaard, L., Aamand, R., Gutiérrez Jiménez, E., Ho, Y. C. L., Blicher, J., Madsen, S. M., Nagenthiraja, K., Dalby, R. B., Drasbek, K. R., Møller, A., Brændgaard, H., Mouridsen, K., Jespersen, S. N., Jensen, M. S. & West, M. J. (2013). The capillary dysfunction hypothesis of Alzheimer's disease. Neurobiology of Aging, 34(4), 1018-31. https://doi.org/10.1016/j.neurobiolaging.2012.09.011

Brooks, D. J. & Amyloid PET Study Group (2015). Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. JAMA: The Journal of the American Medical Association, 313(19), 1939-1949. https://doi.org/10.1001/jama.2015.4669

Opacka-Juffry, J., Ashworth, S., Hume, S. P., Martin, D., Brooks, D. J. & Blunt, S. B. (1995). GDNF protects against 6-ohda nigrostriatal lesion: In vivo study with microdialysis and PET. NeuroReport, 7(1), 348-352. https://doi.org/10.1097/00001756-199512290-00083

Olsen, G. M., Scheel-Krüger, J., Møller, A. & Jensen, L. H. (1994). Does neuronal damage of CA1 relate to spatial memory performance of rats subjected to transient forebrain ischemia. Acta Neurologica Scandinavica, 89, 204-209.

Olsen, G. M., Scheel-Krüger, J., Møller, A. & Jensen, L. H. (1994). Relation of spatial learning of rats in the morris water maze task to the number of viable CA1 neurons following four-vessel occlusion. Behavioral Neuroscience, 108, 681-690.

Olesen, S.-P., Møller, A., Morvintcev, P. I., Busse, R. & Mülsch, A. (1995). Ischemia promotes formation of nitric oxide in different regions of rat brain in vivo. The Biology of Nitric Oxide.

Olesen, S.-P., Møller, A., Mordvintcev, P. I., Busse, R. & Mülsch, A. (1997). Regional measurements of NO formed in vivo during brain ischemia. Acta Neurologica Scandinavica, 95, 219-224.

Okkels, N., Horsager, J., Pavese, N., Brooks, D. J. & Borghammer, P. (2023). Cholinergic Imaging and Dementia. In Molecular Imaging of Neurodegenerative Disorders (pp. 127-144). Springer International Publishing. https://doi.org/10.1007/978-3-031-35098-6_8

Okello, A., Edison, P., Archer, H. A., Turkheimer, F. E., Kennedy, J., Bullock, R., Walker, Z., Kennedy, A., Fox, N., Rossor, M. & Brooks, D. J. (2009). Microglial activation and amyloid deposition in mild cognitive impairment: A PET study. Neurology, 72(1), 56-62. https://doi.org/10.1212/01.wnl.0000338622.27876.0d

Okello, A., Koivunen, J., Edison, P., Archer, H. A., Turkheimer, F. E., Någren, K., Bullock, R., Walker, Z., Kennedy, A., Fox, N. C., Rossor, M. N., Rinne, J. O. & Brooks, D. J. (2009). Conversion of amyloid positive and negative mci to ad over 3 years: An c-pib pet study symbol. Neurology, 73(10), 754-760. https://doi.org/10.1212/WNL.0b013e3181b23564

O’Brien, J. T., Chouliaras, L., Sultana, J., Taylor, J. P., Ballard, C. & on behalf of the RENEWAL Study Group (2022). RENEWAL: REpurposing study to find NEW compounds with Activity for Lewy body dementia—an international Delphi consensus. Alzheimer's Research & Therapy, 14(1), Article 169. https://doi.org/10.1186/s13195-022-01103-7

Obeso, J. A., Stamelou, M., Goetz, C. G., Poewe, W., Lang, A. E., Weintraub, D., Burn, D., Halliday, G. M., Bezard, E., Przedborski, S., Lehericy, S., Brooks, D. J., Rothwell, J. C., Hallett, M., DeLong, M. R., Marras, C., Tanner, C. M., Ross, G. W., Langston, J. W. ... Stoessl, A. J. (2017). Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy. Movement Disorders, 32(9), 1264-1310. https://doi.org/10.1002/mds.27115

Nuti, A., Lucetti, C., Pavese, N., Dell'Agnello, G., Rossi, G. & Bonuccelli, U. (1996). Long-term follow-up after flunarizine or nimodipine discontinuation in migraine patients. Cephalalgia, 16(5), 337-340. https://doi.org/10.1046/j.1468-2982.1996.1605337.x

Nuti, A., Maremmani, C., Ceravolo, R., Pavese, N., Bonuccelli, U. & Muratorio, A. (1991). TERAPIA CON DESAMETAZONE NELLA COREA DI HUNTINGTON: RISULTATI PRELIMINARI. Rivista di Neurologia, 61(6), 225-227.

Nordberg, A., Carter, S. F., Rinne, J., Drzezga, A., Brooks, D. J., Vandenberghe, R., Perani, D., Forsberg, A., Långström, B., Scheinin, N., Karrasch, M., Någren, K., Grimmer, T., Miederer, I., Edison, P., Okello, A., Van Laere, K., Nelissen, N., Vandenbulcke, M. ... Herholz, K. (2013). A European multicentre PET study of fibrillar amyloid in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging, 40(1), 104-14. https://doi.org/10.1007/s00259-012-2237-2

Nombela, C., Rowe, J. B., Winder-Rhodes, S. E., Hampshire, A., Owen, A. M., Breen, D. P., Duncan, G. W., Khoo, T. K., Yarnall, A. J., Firbank, M. J., Chinnery, P. F., Robbins, T. W., O'Brien, J. T., Brooks, D. J., Burn, D. J., Barker, R. A. & ICICLE-PD Study Group (2014). Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study. Brain, 137(Pt 10), 2743-58. https://doi.org/10.1093/brain/awu201

Nielsen, E. Ø., Warming, T., Mathiesen, C., Jensen, L. H., Møller, A., Gouliaev, A. H., Wätjen, F. & Drejer, J. (1999). SPD 502: A water-soluble and in vivo long-lasting AMPA antagonisk with neuroprotective activity. The Journal of Pharmacology and Experimental Therapeutics, 289, 1492-1501.

Nielsen, R. B., Egefjord, L., Angleys, H., Mouridsen, K., Gejl, M., Møller, A., Brock, B., Brændgaard, H., Gottrup, H., Rungby, J., Eskildsen, S. F. & Østergaard, L. (2017). Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease. Alzheimer's & Dementia, 13(10), 1143-1153. https://doi.org/10.1016/j.jalz.2017.02.007

Nielsen, R. B., Egefjord, L., Eskildsen, S. F., Møller, A., Brændgaard, H., Jensen, M. G., Brock, B., Rungby, J. & Østergaard, L. (2016). Disruption of microvascular flow-patterns in Alzheimer's disease correlates with neurodegeneration and cognitive decline. Abstract from 10th FENS FORUM of Neuroscience 2016, København, Denmark.

Nielsen, R. B., Parbo, P., Ismail, R., Dalby, R., Tietze, A., Braendgaard, H., Gottrup, H., Brooks, D. J., Ostergaard, L. & Eskildsen, S. F. (2019). Impaired perfusion and capillary distribution of blood in mild cognitive impairment: Relation to oxygenation and amyloid load. Journal of Cerebral Blood Flow and Metabolism, 39(1, suppl.), 147. Article PA00-A28. https://doi.org/10.1177/0271678X19851017

Nielsen, R. B., Parbo, P., Ismail, R., Dalby, R., Tietze, A., Brændgaard, H., Gottrup, H., Brooks, D. J., Østergaard, L. & Eskildsen, S. F. (2020). Impaired perfusion and capillary dysfunction in prodromal Alzheimer's disease. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 12(1), Article e12032. https://doi.org/10.1002/dad2.12032

Nielsen, S. V., Dollerup, M. R., Baerentzen, S. L., Landau, A., Munk, O. L. & Alstrup, A. K. O. (2022). Validation and optimization of an automatic blood sampler for preclinical positron emission tomography (PET) research in domestic pigs. Laboratory Animals, 56(3), 287-291. Article 236772211049081. https://doi.org/10.1177/00236772211049081

Nielsen, R. B., Parbo, P., Ismail, R., B Dalby, R., Tietze, A., Brændgaard, H., Gottrup, H., Brooks, D. J., Østergaard, L. & Eskildsen, S. F. (2025). Diffusion kurtosis imaging detects cortical microstructural alterations in amyloid-positive MCI patients. Frontiers in dementia, 4, Article 1725754. https://doi.org/10.3389/frdem.2025.1725754

Nicolson, R. I., Fawcett, A. J., Berry, E. L., Jenkins, I. H., Dean, P. & Brooks, D. J. (1999). Association of abnormal cerebellar activation with motor learning difficulties in dyslexic adults. Lancet, 353(9165), 1662-1667. https://doi.org/10.1016/S0140-6736(98)09165-X

Nicholl, D. J., Vaughan, J. R., Khan, N. L., Ho, S. L., Aldous, D. E. W., Lincoln, S., Farrer, M., Gayton, J. D., Davis, M. B., Piccini, P., Daniel, S. E., Lennox, G. G., Brooks, D. J., Williams, A. C. & Wood, N. W. (2002). Two large British kindreds with familial Parkinson's disease: A clinico-pathological and genetic study. Brain, 125(1), 44-57. https://doi.org/10.1093/brain/awf013

Nicholas, R., Brooks, D. & Owen, D. (2020). In Response to Letter from Fregonara et al. 2019. Molecular Imaging and Biology, 22(1), 13-14. https://doi.org/10.1007/s11307-019-01463-x

Nicholas, R., Brooks, D. & Owen, D. (2020). 18F-GE180, a radioligand for the TSPO protein: not ready for clinical trials in multiple sclerosis. European journal of nuclear medicine and molecular imaging, 47(10), 2242-2243. https://doi.org/10.1007/s00259-020-04844-5

Nelissen, N., Van Laere, K., Thurfjell, L., Owenius, R., Vandenbulcke, M., Koole, M., Bormans, G., Brooks, D. J. & Vandenberghe, R. (2009). Phase 1 study of the Pittsburgh compound B derivative¹⁸F- flutemetamol in healthy volunteers and patients with probable Alzheimer disease. Journal of Nuclear Medicine, 50(8), 1251-1259. https://doi.org/10.2967/jnumed.109.063305

Nahimi, A., Høltzermann, M., Simonsen, M., Jacobsen, S., Møller, A., Wegener, G., Gjedde, A. & Doudet, D. (2009). Serotoninergic modulation of exogenous L-DOPA-derived dopamine release in rats with unilateral 6-OHDA lesions revealed with microPET imaging: Poster. Scandinavian Neuropsychopharmacology, 23-23.

Nahimi, A., Holtzermann, M., Landau, A. M., Møller, A., Alstrup, A. K. O., Wegener, G., Doudet, D. & Gjedde, A. (2010). Serotonergic modulation of release of dopamine from endogenous L-DOPA in rats with unilateral 6-OHDA lesions. Abstract from 16th World Congress of Basic and Clinical Pharmacology, København, Denmark.

Nahimi, A., Olsen, A. K., Møller, A., Jakobsen, S., Østergaard, S. D. & Doudet, D. (2007). Role of monoaminergic innervation in 6-hydroxydopamine unilateral lesioned animal model of Parkinsons Disease and L-DOPA induced dyskinesia. Abstract from OAK Meeting, København, Denmark.

Nahimi, A., Høltzermann, M., Landau, A. M., Simonsen, M., Jakobsen, S., Alstrup, A. K. O., Wang, K., Møller, A., Wegener, G., Gjedde, A. & Doudet, D. (2011). Serotonergic modulation of receptor occupance in rats treated with L-DOPA after unilateral 6-OHDA lesioning. Poster session presented at The Brain Prize Meeting, Aarhus, Denmark.

Nahimi, A., Høltzermann, M., Landau, A. M., Simonsen, M. K., Jakobsen, S., Alstrup, A. K. O., Vang, K., Møller, A., Wegener, G., Gjedde, A. & Doudet, D. J. (2012). Serotonergic modulation of receptor occupancy in rats treated with L-DOPA after unilateral 6-OHDA lesioning. Journal of Neurochemistry, 120(5), 806-817. https://doi.org/10.1111/j.1471-4159.2011.07598.x

Nagahama, Y., Fukuyama, H., Turjanski, N., Kennedy, A., Yamauchi, H., Ouchi, Y., Kimura, J., Brooks, D. J. & Shibasaki, H. (1997). Cerebral glucose metabolism in corticobasal degeneration: Comparison with progressive supranuclear palsy and normal controls. Movement Disorders, 12(5), 691-696. https://doi.org/10.1002/mds.870120510

Myers, J. F. M., Rosso, L., Watson, B. J., Wilson, S. J., Kalk, N. J., Clementi, N., Brooks, D. J., Nutt, D. J., Turkheimer, F. E. & Lingford-Hughes, A. R. (2012). Characterisation of the contribution of the GABA-benzodiazepine α1 receptor subtype to [(11)C]Ro15-4513 PET images. Journal of Cerebral Blood Flow and Metabolism, 32(4), 731-44. https://doi.org/10.1038/jcbfm.2011.177

Mullin, S., Stokholm, M. G., Hughes, D., Mehta, A., Parbo, P., Hinz, R., Pavese, N., Brooks, D. J. & Schapira, A. H. (2021). Brain Microglial Activation Increased in Glucocerebrosidase (GBA) Mutation Carriers without Parkinson's disease. Movement Disorders, 36(3), 774-779. https://doi.org/10.1002/mds.28375

Müller, G. J., Møller, A. & Johansen, F. F. (2001). Stereological cell counts of GABAergic neurons in rat dentate hilus following transient cerebral ischemia. Exp. Brain Research, 141, 380-388.

Mouritzen-Dam, A., Møller, A., Scheel-Krüger, J., Jensen, L. H., Marescaux, C. & Vergnes, M. (1996). Total number of neurons in the ventro-lateral/posterior thalamic nuclei in a genetic petit mal-like rat strain. Epilepsy Res. Suppl., 12, 303-307.

Morrish, P. K., Rakshi, J. S., Bailey, D. L., Sawle, G. V. & Brooks, D. J. (1998). Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [¹⁸F] dopa PET. Journal of Neurology Neurosurgery and Psychiatry, 64(3), 314-319. https://doi.org/10.1136/jnnp.64.3.314

Displaying results 201 to 400 out of 1081

Revised 01.06.2022

Henriette Blæsild Vuust